ciprofloxacin has been researched along with asparagine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deguchi, T; Kawada, Y; Kawamura, T; Nakano, M; Nishino, Y; Ozeki, S; Yasuda, M | 1 |
Aires, JR; McDermott, G; Nikaido, H; Yu, EW | 1 |
2 other study(ies) available for ciprofloxacin and asparagine
Article | Year |
---|---|
Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.
Topics: Anti-Infective Agents; Asparagine; Ciprofloxacin; DNA Gyrase; DNA Topoisomerases, Type II; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Humans; Incidence; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Serine; Urinary Tract Infections | 1997 |
A periplasmic drug-binding site of the AcrB multidrug efflux pump: a crystallographic and site-directed mutagenesis study.
Topics: Alanine; Anti-Infective Agents; Asparagine; Binding Sites; Carrier Proteins; Ciprofloxacin; Crystallography; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Proteins; Membrane Proteins; Multidrug Resistance-Associated Proteins; Mutagenesis, Site-Directed; Periplasmic Proteins; Plasmids; Protein Structure, Secondary; Protein Structure, Tertiary | 2005 |